1. Home
  2. EDSA vs EXYN Comparison

EDSA vs EXYN Comparison

Compare EDSA & EXYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Edesa Biotech Inc.

EDSA

Edesa Biotech Inc.

HOLD

Current Price

$5.37

Market Cap

51.6M

Sector

Health Care

ML Signal

HOLD

EXYN

Exyn Technologies Inc. Common Stock

N/A

Current Price

$2.45

Market Cap

47.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
EDSA
EXYN
Founded
2015
N/A
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.6M
47.6M
IPO Year
2018
2026

Fundamental Metrics

Financial Performance
Metric
EDSA
EXYN
Price
$5.37
$2.45
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
51.5K
205.9K
Earning Date
05-08-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$1.65
52 Week High
$20.32
$6.98

Technical Indicators

Market Signals
Indicator
EDSA
EXYN
Relative Strength Index (RSI) 43.08 38.37
Support Level $4.80 $1.65
Resistance Level $6.58 $6.90
Average True Range (ATR) 0.57 0.42
MACD 0.07 0.08
Stochastic Oscillator 68.35 50.48

Price Performance

Historical Comparison
EDSA
EXYN

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Share on Social Networks: